e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl
Wang L., Chiang E.T., Simmons J.T., Garcia J.G.N., Dudek S.M.
Source:
Eur Respir J 2011; 37: 78-88
Journal Issue:
July
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Wang L., Chiang E.T., Simmons J.T., Garcia J.G.N., Dudek S.M.. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl. Eur Respir J 2011; 37: 78-88
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Acute respiratory distress syndrome
Antibiotic prescription patterns for treating respiratory infections across intensive care unit (ICUs) in India
Related content which might interest you:
IL18 induces p38 MAP kinase activation and adhesion capacities in BMPRII knocked down human lung microvascular endothelial cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
MAP kinases mediate FGF-induced expression and release of VEGF in human airway smooth muscle cells: The role of azithromycin
Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology
Year: 2011
Crucial role for protein kinase C-α and arginase activation in the induction of pulmonary endothelial hyperpermeability by pneumolysin
Source: Annual Congress 2010 - Acute lung injury: barrier properties and leukocyte activation
Year: 2010
Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway
Source: Eur Respir J 2008; 31: 523-531
Year: 2008
The nitration mediated inhibition of Rac1 is involved in the endothelial barrier dysfunction induced by lipopolysaccharide
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
PDGF and Src tyrosine kinases in pulmonary arterial smooth muscle cells: Effects of dasatinib and nilotinib on pulmonary vascular remodeling
Source: Annual Congress 2011 - Treatments for pulmonary hypertension in human and experimental models
Year: 2011
Potential role of filamin and p38 MAPK in the regulation of human alveolar epithelial cell permeability
Source: Eur Respir J 2002; 20: Suppl. 38, 96s
Year: 2002
Stimulation of NOD1 induces RIP2, TAK1 and p38 MAPK dependent pro-inflammatory signalling in human lung microvascular endothelial cells
Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment
Year: 2011
PTEN reduces vascular endothelial growth factor–mediated vascular permeability in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 581s
Year: 2005
N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells
Source: Eur Respir J 2003; 22: 43-49
Year: 2003
Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1137-1149
Year: 2016
Effects of glucocorticoids on activation of extracellular signal-regulated kinases (ERK) in human pulmonary endothelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 160s
Year: 2001
Tyrosine kinase inhibition of human pulmonary fibroblast migration
Source: Eur Respir J 2005; 26: Suppl. 49, 101s
Year: 2005
Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries
Source: Eur Respir J 2013; 41: 85-95
Year: 2013
YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK, ERK1/2) and NF-κB pathways, causing bronchial smooth muscle proliferation and migration
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012
Alkalosis induce eNOS activation in human pulmonary arterial endothelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 73s
Year: 2001
PKC inhibits BK
Ca
channel activity in pulmonary arterial smooth muscle cells through multiple signaling pathways
Source: Eur Respir J 2006; 28: Suppl. 50, 159s
Year: 2006
Caveolin-1 regulation of thrombin signalling in endothelial cells
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009
Blocking Focal adhesion kinase (FAK) protects against damage in a novel model of lymphocyte dominant lung injury
Source: Virtual Congress 2020 – Cellular involvement in lung injury
Year: 2020
Hypoxia-induced increase in NO production and eNOS expression by murine pulmonary microvascular endothelial cells
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept